Skip directly to content

News

Text Increase:
Text Increase Normal
Text Increase Large
Text Increase Largest

Walkathon to benefit diabetes research

Khaasbaat: A Publication for Indian Americans in Florida noted Dr. Koshy’s participation in a local walkathon to benefit diabetes research and education efforts. (Note that University Community Hospital is now Florida Hospital-Tampa.) Here’s the scoop.

2014 Data Show More Than One Quarter of U.S. Adults Are Obese

A recently released study from the Gallup survey firm indicates that Americans’ health worries related to obesity aren’t getting any smaller. In fact, according to self-reported height and weight measurements of 167,000 people who were surveyed by the firm in 2014, the U.S. obesity rate can now be pegged as high as 27.7 percent – up from 27.1 percent in 2013 and more than two percentage points higher than in 2008. Given the increased risk that obese patients face of contracting serious illnesses ranging from cardiovascular disease to dementia, diabetes and even cancer, it stands to reason that this apparent trend can indeed be termed a health epidemic. Read all about it on the Gallup website.

New Study Adds Credence to Thyroid-Fertility Link

Endocrinologists have long suspected that thyroid disease can adversely impact a woman’s fertility and her ability to have a complication-free pregnancy. A newly published study supports this notion and adds credibility to the idea that routine thyroid testing is a good idea for pregnant women as well as women who are having difficulty conceiving. Read all about it in U.S. News & World Report.

“Smart” Insulin Could Help Diabetics Stay in Control

The BBC and other media channels recently reported on a potential medical breakthrough in the treatment of Type 1 diabetes. So-called “smart” insulins are being developed that could alleviate the need for frequent checking to make sure that blood glucose levels don’t go too low after an injection. These insulins are designed to automatically activate when needed and shut off when glucose levels return to normal. Researchers have apparently had good results in animal trials, and may soon be testing this exciting new therapy in humans. Read the BBC’s complete coverage here.